Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	384.26	155.89	183.42	287.5	243.77
Cash & Cash Equivalents	384.26	155.89	183.42	287.5	243.77
Cash Growth	146.49%	-15.01%	-36.20%	17.94%	27632.08%
Receivables	1.64	0	0	0	0
Inventory	9.44	0	0	0	0
Other Current Assets	2.1	4.62	3.11	3.87	11.84
Total Current Assets	397.43	160.51	186.53	291.37	255.6
Property, Plant & Equipment	3.62	3.49	2.56	3.36	1.4
Other Long-Term Assets	12.79	0.8	0.34	0.38	0.18
Total Long-Term Assets	16.41	4.3	2.91	3.74	1.58
Total Assets	413.84	164.81	189.43	295.11	257.18
Accounts Payable	12.6	10	5.15	16.78	0.7
Current Debt	0.73	0.71	0.49	7.83	0.16
Other Current Liabilities	25.45	15.53	13.28	30.92	2.89
Total Current Liabilities	38.78	26.24	18.92	55.52	3.75
Long-Term Debt	438.12	205.89	90.85	41.19	23.41
Other Long-Term Liabilities	9.7	7.5	7.5	4.13	2.06
Total Long-Term Liabilities	447.82	213.39	98.35	45.32	25.48
Total Liabilities	486.6	239.62	117.28	100.84	29.22
Total Debt	438.85	206.6	91.34	49.02	23.57
Debt Growth	112.42%	126.18%	86.34%	107.94%	1108.87%
Retained Earnings	-928.69	-727.09	-529.37	-385.49	-256.42
Shareholders' Equity	-72.76	-74.81	72.16	194.27	227.96
Net Cash / Debt	-54.59	-50.71	92.08	238.48	220.19
Net Cash / Debt Growth	-	-	-61.39%	8.30%	-
Net Cash Per Share	-1.06	-1.30	2.49	7.18	19.37
Working Capital	358.65	134.28	167.61	235.84	251.85
Book Value Per Share	-1.42	-1.91	1.95	5.85	20.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).